How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

32,043 results for

Hypertension Evaluation History

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Can You Say the C Word on the Ward? Chronicity, Cure, Care and the History of Hospital Medicine.

Can You Say the C Word on the Ward? Chronicity, Cure, Care and the History of Hospital Medicine. Renal Fellow Network: Can You Say the C Word on the Ward? Chronicity, Cure, Care and the History of Hospital Medicine. | | | | | Tuesday, February 20, 2018 Can You Say the C Word on the Ward? Chronicity, Cure, Care and the History of Hospital Medicine. ‘That was so cool! He looked a thousand times better! And his bloods too!’ Rob, our junior resident, was bounding down the stairs beside me (...) years, now tired and off his food with what sounded like a diabetic foot infection. ‘Yes, cubicle 3. 76 year old man. I’ve pre-filled his history notes. The usual...’ I watched Rob’s shoulders hunch with a familiar burden: ‘..CKD5D, CAD, CCF, COPD…all the C words. Oh, and diabetes and OSA and gout.’ All the C words. In 1984, Mt Sinai Hospital’s director declared that, in hospitals, . Could this still be true? We work in a healthcare model which, despite a comprehensive network of community services

2018 Renal Fellow Network

62. BNP in the Evaluation of Syncope

. His wife helped him clean the mashed potatoes off his face and brought him to the ED. His past medical history includes hypertension and diet-controlled diabetes, and he endorses a family history of coronary artery disease in both parents. He denies chest pain, shortness of breath, or palpitations, and his vital signs and physical exam are currently normal. You go to put in orders, including an EGC, BMP, CBC, and troponin, when your large Russian attending, whose hairstyle reminds you of Eddie (...) BNP in the Evaluation of Syncope Emergency Medicine > Journal Club > Archive > August 2018 Toggle navigation August 2018 BNP in the Evaluation of Syncope Vignette You are working an evening shift in your ED as the senior resident when you encounter Mr. Drop, a 58-year old male presenting with syncope. He was sitting at the dinner table, getting ready to eat when he suddenly lost consciousness and fell face-first into his mashed potatoes. he had no seizure activity and awoke within a few seconds

2018 Washington University Emergency Medicine Journal Club

63. Diagnostic evaluation of cryptogenic stroke

Diagnostic evaluation of cryptogenic stroke Diagnostic Evaluation of Cryptogenic Stroke – Clinical Correlations Search Diagnostic Evaluation of Cryptogenic Stroke April 2, 2019 8 min read Dixon Yang, MD Peer Reviewed Case and Introduction A 52-year-old right-handed woman with hypertension is brought in by ambulance after her daughter notices a sudden onset of nonsensical speech and trouble walking. On exam, she has an expressive aphasia with right-sided hemiparesis. Her vitals are stable (...) a few atrial premature complexes and cardiac ultrasound reveals only a small inter-atrial shunt. At this point, the etiology of her ischemic stroke remains unclear. How should this case be further evaluated? Despite advances in testing, many ischemic strokes are y [1,2]. Less well-understood mechanisms are thought to comprise of cryptogenic strokes including occult arrhythmias, paradoxical emboli, undefined hypercoagulable states, and atherosclerotic disease of the aorta or supra-aortic vasculature

2019 Clinical Correlations

64. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

, history of diabetes, history of prior myocardial infarction, history of heart failure, and prior aspirin use. †For comparative effectiveness recommendations (Class I and IIa; Level of Evidence A and B only), studies that support the use of comparator verbs should involve direct comparisons of the treatments or strategies being evaluated. Downloaded from http://ahajournals.org by on March 27, 2019Management of Comorbidities in Chronic Heart Failure Circulation. 2016;134:e535–e578. DOI: 10.1161/CIR (...) of atherosclerotic vascular Downloaded from http://ahajournals.org by on March 27, 2019Bozkurt et al December 6, 2016 Circulation. 2016;134:e535–e578. DOI: 10.1161/CIR.0000000000000450 e548 disease, diabetes mellitus, or hypertension with associated cardiovascular risk factors (Class IIa; Level of Evidence A). 3. ARBs can be useful to prevent HF in patients at high risk for developing HF who have a history of atherosclerotic vascular disease, diabetes mellitus, or hypertension with asso- ciated cardiovascular

Full Text available with Trip Pro

2016 American Heart Association

65. Portal Hypertension Bleeding in Cirrhosis, Guidance

Portal Hypertension Bleeding in Cirrhosis, Guidance Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases - Garcia‐Tsao - 2017 - Hepatology - Wiley Online Library Search within Search term Search term Practice Guidance Free Access Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association (...) , Hepatic Hemodynamic Laboratory, Institute of Biomedical Research, August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain First published: 27 October 2016 Cited by: Potential conflict of interest: Dr. Bosch consults for Gilead, Conatus, Exalenz, Actelion, Chiasma, and Novo A/S. Dr. Garcia‐Tsao consults for BioVie, Conatus, Galectin and Intercept. Correction added May 30, 2017, after publication: the keyword “portal hypertension” was added. All AASLD Practice Guidelines are updated

Full Text available with Trip Pro

2016 American Association for the Study of Liver Diseases

66. Hypertensive disorders of pregnancy

to online version, destroy printed copies after use Page 18 of 32 7.2 Maternal and fetal surveillance Adverse perinatal outcome is increased in women with all subcategories of hypertensive disease in pregnancy as compared to normotensive women. Table 17. Maternal and fetal surveillance Aspect Considerations Plan of care • Discuss and agree a plan with each woman about antenatal surveillance and birth that takes into account: o Maternal preferences o Previous history, risk factors for preeclampsia (...) Hypertensive disorders of pregnancy Maternity and Neonatal C linical G uideline Queensland Health Hypertensive disorders of pregnancy Queensland Clinical Guideline: Hypertensive disorders of pregnancy Refer to online version, destroy printed copies after use Page 2 of 32 Document title: Hypertensive disorders of pregnancy Publication date: August 2015 Document number: MN15.13-V7-R20 Document supplement: The document supplement is integral to and should be read in conjunction with this guideline

2016 Queensland Health

67. Suspected Pulmonary Hypertension

of the nonspecific symptoms as well as the large, diverse group of diseases that can cause PH, diagnosis can be challenging. A careful history is critical to evaluate for risk factors for PH, including family history, history of drugs and toxins associated with PH, collagen vascular disease, human immunodeficiency virus (HIV), portal hypertension, congenital or left heart disease, and venous thromboembolic disease [11,12]. Clinical evaluation includes pulmonary function tests, arterial blood gases, routine (...) is usually performed during the initial workup/screening of suspected pulmonary hypertension and is often the first test performed. ? CTA chest with IV contrast 8 This procedure is equivalent to CT chest with IV contrast. The examination choice of CTA chest with IV contrast or CT chest with IV contrast depends on institutional preference. ??? Tc-99m V/Q scan lung 8 This procedure is the examination of choice to evaluate for CTEPH. ??? CT chest with IV contrast 7 This procedure is equivalent to CTA chest

2016 American College of Radiology

68. Natural History of Noncirrhotic Portal Hypertension

diseases and the different underlying biological processes that lead to the development of NCPH. We also aim to further the scant existing knowledge regarding the natural history of this disease and the global phenomenon of portal hypertension. From the data obtained from this natural history protocol, future studies will be planned to evaluate specific hypothesis in specific disease cohorts. Patients with diseases known to cause cirrhosis will be excluded. Patients 12 years of age and older thought (...) Natural History of Noncirrhotic Portal Hypertension Natural History of Noncirrhotic Portal Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Natural History of Noncirrhotic Portal Hypertension

2015 Clinical Trials

69. Association Between Family History and Hypertension Among Chinese Elderly. (PubMed)

Association Between Family History and Hypertension Among Chinese Elderly. This study aimed to evaluate the association between family history and prevalence of hypertension among Chinese community elderly, and also explore the gender difference. A population-based cross-sectional study was conducted in Miyun district of Beijing, in 2014. The family history information was obtained from each subject and was divided into 3 categories, no family history (FH0), 1 generation of first-degree (...) relatives with hypertension (FH1), and 2 generations of first-degree relatives with hypertension (FH2). The prevalence of hypertension was 53.0%. Participants with positive family history had a significantly higher prevalence of hypertension (67.5%, 95% CI: 63.3-71.7) than those without (47.9%, 95% CI: 45.2-50.6), and even among participants without hypertension, the blood pressure levels were higher with positive FH. Multiple logistic regression analysis showed that a significantly linear-trend

Full Text available with Trip Pro

2015 Medicine

70. The influence of family history of Hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. (PubMed)

representative sample from Sri Lanka.A cross-sectional survey among 5,000 Sri Lankan adults, evaluating FH at the levels of parents, grandparents, siblings and children. A binary logistic regression analysis was performed in all patients with 'presence of hypertension' as dichotomous dependent variable and using family history in parents, grandparents, siblings and children as binary independent variables. The adjusted odds ratio controlling for confounders (age, gender, body mass index, diabetes (...) The influence of family history of Hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. Hypertension is a major contributor to the global non-communicable disease burden. Family history is an important non-modifiable risk factor for hypertension. The present study aims to describe the influence of family history (FH) on hypertension prevalence and associated metabolic risk factors in a large cohort of South Asian adults, from a nationally

Full Text available with Trip Pro

2015 BMC Public Health

71. Multidrug intolerance in the treatment of hypertension: result from an audit of a specialized hypertension service (PubMed)

intolerance (MDI) is hardly considered. A situation when a patient is willing to adhere but is compelled otherwise could frustrate both patient and physician. Encountering a few such cases prompted the author to audit his specialized hypertension service in order to evaluate the burden of MDI and its associations.Between 7 May and 30 July 2016 (to cover a 12-week cycle which ensured all attendees were captured), all patients attending follow up for blood pressure control had their records evaluated (...) -morbidity. A total of four patients (three men, one woman) had history suggesting allergy and two (one man, one woman) were on treatment for anxio-depressive illness.MDI does occur in sub-Sahara African patients with hypertension and should be considered before describing hypertension as resistant or considering alternative treatments including device therapy. Staggering doses or trying different formulations could be of benefit.

Full Text available with Trip Pro

2017 Therapeutic advances in drug safety

72. Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes (PubMed)

hypertension among GDM women. To evaluate the association between HDP and the risk of postpartum hypertension among GDM women, a retrospective cohort study was conducted in 1261 women with prior GDM at their postpartum 1-5 years using the baseline data from Tianjin Gestational Diabetes Mellitus Prevention Program. Cox regression models were applied to assess the single and joint associations of having a history of HDP, maternal pre-pregnancy Body mass index (BMI) (normal weight, overweight and obesity (...) ), and weight change from preconception to post-delivery with the risk of subsequent hypertension among the GDM women. We found that GDM women with a history of HDP, high pre-pregnancy BMI and weight gain >7 kg from preconception to post-delivery had an increased risk of postpartum hypertension. Joint effects analysis revealed that the positive association between a history of HDP in the index pregnancy and the risk of postpartum hypertension was consistent in GDM women with different levels of pre

Full Text available with Trip Pro

2017 Journal of human hypertension

73. Hypertension Evaluation History

Hypertension Evaluation History Hypertension Evaluation History Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hypertension (...) Evaluation History Hypertension Evaluation History Aka: Hypertension Evaluation History From Related Chapters II. History: Past Medical History Severity of with log Onset of Age <12: Associated with in >70% of cases Age 12-18: Associated with in 10-15% of cases Age 19-39: Associated with in 5% of cases Age 40-64: Associated with in 8-12% of cases Age >65: Associated with in 17% of cases III. History: Family History disease IV. History: Medications See V. History: Habits Salt intake Fat intake High

2015 FP Notebook

74. Hirsutism: Evaluation and Treatment

. Evaluation A thorough history and physical examination plus selected laboratory evaluations will confirm the diagnosis and direct treatment. Treatment Pharmacologic interventions can suppress ovarian or adrenal androgen production and block androgen receptors in the hair follicle. Hair removal methods and lifestyle modifications may improve or hasten the therapeutic response. Outcomes At least 6 to 9 months of therapy are required to produce improvement in hirsutism. Evidence The quality of evidence (...) should be evaluated with a focused history, physical examination, and appropriate investigations to differentiate among the possible etiologies (III-B). 2. Laboratory investigations for women with moderate to severe hirsutism should include total testosterone, although the benefit in mild hirsutism is questionable. Additional testing is indicated for women with irregular menses and/or signs of hyperandrogenism or other endocrinopathies (III-B). 3. Referral for evaluation by an endocrinologist

2017 Society of Obstetricians and Gynaecologists of Canada

75. Symptoms, natural history and outcomes of early chronic kidney disease

Symptoms, natural history and outcomes of early chronic kidney disease ________________________________________________________________________________________________________________________ Early Chronic Kidney Disease July 2012 Page 1 of 12 Symptoms, natural history and outcomes of early chronic kidney disease Date written: July 2012 Author: Kate Wiggins, David Johnson EVIDENCE SUMMARY a. Chronic kidney disease is associated with increased risks of death from any cause, cardiovascular events (...) awareness of the clinical significance of early CKD is important so as to promote compliance with therapies aimed at retarding disease progression and reducing complications. In this guideline the currently available evidence regarding outcomes and complications of CKD is evaluated. A particular emphasis is placed on outcomes and symptoms that are likely to be deemed significant by people diagnosed with early stage of CKD

2013 KHA-CARI Guidelines

76. Recurrence risk and prediction of a delivery under 34 weeks of gestation after a history of a severe hypertensive disorder. (PubMed)

Recurrence risk and prediction of a delivery under 34 weeks of gestation after a history of a severe hypertensive disorder. The aim of this study was to report outcomes of the subsequent pregnancy after early-onset pre-eclampsia in a first pregnancy (index), and to evaluate the potential risk factors for recurrence of pre-eclampsia and preterm delivery.We performed a retrospective cohort study of all women who developed early-onset pre-eclampsia (delivery before 34 weeks of gestation (...) ) in their first pregnancy between January 1996 and December 2004 in two perinatal centres with regional function. All patients were included consecutively. Information was retrieved on the course of subsequent pregnancies.Two tertiary centres with regional function.Women with a delivery under 34 weeks due to a hypertensive disorder (N=380).We determined the absolute risk of recurrence of an adverse outcome, defined as a hypertensive complication resulting in delivery before 34 weeks of gestation

Full Text available with Trip Pro

2011 EvidenceUpdates

77. Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs (PubMed)

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs The purpose of this study was to investigate predictors of bleeding in a cohort of anticoagulated patients and to evaluate the predictive value of several bleeding risk stratification schemas.The risk of bleeding during antithrombotic therapy (...) (Stroke Prevention Using an ORal Thrombin Inhibitor in Atrial Fibrillation) III and V clinical trials and evaluated the predictive value of several risk stratification schemas by multivariate analysis. Patients were anticoagulated orally with either adjusted-dose warfarin (target international normalized ratio 2 to 3) or fixed-dose ximelagatran 36 mg twice daily. Major bleeding was centrally adjudicated, and concurrent aspirin therapy was allowed in patients with clinical atherosclerosis.By

Full Text available with Trip Pro

2011 EvidenceUpdates

78. Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. (PubMed)

Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. To evaluate whether history of pregnancy complications [pre-eclampsia, gestational hypertension, preterm delivery, or small for gestational age (SGA)] improves risk prediction for cardiovascular disease (CVD).This population-based, prospective cohort study linked data from the HUNT Study, Medical Birth Registry of Norway, validated hospital records, and Norwegian Cause (...) of Death Registry. Using an established CVD risk prediction model (NORRISK 2), we predicted 10-year risk of CVD (non-fatal myocardial infarction, fatal coronary heart disease, and non-fatal or fatal stroke) based on established risk factors (age, systolic blood pressure, total and HDL-cholesterol, smoking, anti-hypertensives, and family history of myocardial infarction). We evaluated whether adding pregnancy complication history improved model fit, calibration, discrimination, and reclassification

Full Text available with Trip Pro

2018 European Heart Journal

79. Computerized Medical History Taking for Acute Chest Pain

. Costs will be obtained patient-by-patient from medical records Patient experience with computer-assisted patient entered history measured as he proportion of patients who complete a computer-assisted patient entered history [ Time Frame: 7 days ] To evaluate the proportion of patients who complete a full computer-assisted patient entered history. The ability of computer-assisted patient entered history, as compared to standard history obtained by the cardiologist in attendance to provide information (...) required to calculate a TIMI risk score for an ACS. [ Time Frame: 7 and 30 days ] To compare the proportions of patients with computer-assisted patient entered history, as compared to standard history obtained by the cardiologist in attendance, where there is sufficient information documented to calculate the Thrombolysis In Myocardial Infarction (TIMI) score. The TIMI score contains the following information: Age, risk factors for coronary artery disease (family history, hypertension

2018 Clinical Trials

80. Clinical History and Management Recommendations of the Smooth Muscle Dysfunction Syndrome Due to ACTA2 Arginine 179 Alterations (PubMed)

Clinical History and Management Recommendations of the Smooth Muscle Dysfunction Syndrome Due to ACTA2 Arginine 179 Alterations Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complications in smooth muscle-dependent organs. We sought to define the clinical history of SMDS to develop recommendations for evaluation

Full Text available with Trip Pro

2018 Genetics in medicine : official journal of the American College of Medical Genetics

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>